Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paty, D. W.
Right arrow Articles by B. Li, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paty, D. W.
Right arrow Articles by B. Li, D. K.
NEUROLOGY 1988;38:180
© 1988 American Academy of Neurology

MRI in the diagnosis of MS

A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

D. W. Paty, MD, J. J. F. Oger, MD, L. F. Kastrukoff, MD, S. A. Hashimoto, MD, J. P. Hooge, MD, A. A. Eisen, MD, K. A. Eisen, RN, S. J. Purves, MD, PhD, M. D. Low, MD, PhD, V. Brandejs, W. D. Robertson, MD and D. K. B. Li, MD

From the Division of Neurology (Drs. Paty, Oger, Kastrukoff, Hashimoto, Hooge, A. A. Eisen, Purves, and Low, and Ms. Brandejs and K. A. Eisen), Department of Medicine, the Department of Diagnostic Radiology (Drs. Robertson and Li), and the Imaging Research Center, University of British Columbia, Vancouver, British Columbia, Canada.

We compared the diagnostic capabilities of MRI to CT, evoked potentials (EP), and CSF oligoclonal banding analysis in a prospective evaluation of 200 patients with suspected multiple sclerosis (MS). MRI was the best method for demonstrating dissemination in space. An abnormal appropriate EP in monosymptomatic disease was usually supported by MRI and CSF anaylsis as being predictive of MS as a clinical diagnosis. A normal appropriate EP study was not satisfactory because MRI and CSF analysis often did not support a diagnosis of non-MS. When there is agreement between three of these paraclinical studies, the diagnosis of MS is probably unequivocal. For use in research studies, laboratory-supported definite MS (LSDMS) could be diagnosed in 85 patients of the total 200 (42.5%), in 19/38 (50%) of optic neuritis (ON) patients, and in 24/52 (46%) of chronic progressive myelopathy (CPM) patients. MRI was 100% successful in identifying patients who qualified for LSDMS in the ON and CPM groups. In a short follow-up (less than 1 year), 19/200 (10%) went on to develop clinically definite MS (CDMS), and MRI predicted that diagnosis in 18/19 (95%). Only long-term follow-up will show how well these studies and the category of LSDMS predict the development of CDMS. The clinical diagnosis of MS (CDMS), even though only 95% accurate, must remain the gold standard.

Address correspondence and reprint requests to Dr. Paty, Division of Neurology, Vancouver General Hospital, 222–2775 Heather Street, Vancouver, B. C., Canada V5Z 3J5.

Supported by grants from the Medical Research Council of Canada and the Jacob W. Cohen Fund for Research into Multiple Sclerosis.

Presented in part at the thirty-eighth annual meeting of the American Academy of Neurology, New Orleans, LA, April 1986; and the annual meetings of the American Association of Electromyography and Electrodiagnosis, Boston, MA, September 1986; the American EEG Society, Seattle, WA, November 1986; the Society for Magnetic Resonance, Montreal, Canada, 1986; and the NATO MS Workshop, Brussels, Belgium, 1986.

Received March 16, 1987. Accepted for publication in final form May 11, 1987.




This article has been cited by other articles:


Home page
Mult SclerHome page
T Matsushita, N Isobe, T Matsuoka, N Shi, Y Kawano, X. Wu, T Yoshiura, Y Nakao, T Ishizu, and J. Kira
Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese
Multiple Sclerosis, July 1, 2009; 15(7): 834 - 847.
[Abstract] [PDF]


Home page
Arch NeurolHome page
A. Rovira, J. Swanton, M. Tintore, E. Huerga, F. Barkhof, M. Filippi, J. L. Frederiksen, A. Langkilde, K. Miszkiel, C. Polman, et al.
A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
Arch Neurol, May 1, 2009; 66(5): 587 - 592.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Seewann, H. Vrenken, P. van der Valk, E. L. A. Blezer, D. L. Knol, J. A. Castelijns, C. H. Polman, P. J. W. Pouwels, F. Barkhof, and J. J. G. Geurts
Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis
Arch Neurol, May 1, 2009; 66(5): 601 - 609.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. Dickinson, D. Perera, A. van der Mei, A-L Ponsonby, A. Polanowski, R. Thomson, B. Taylor, J. McKay, J Stankovich, and T Dwyer
Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction
Multiple Sclerosis, May 1, 2009; 15(5): 563 - 570.
[Abstract] [PDF]


Home page
NeurologyHome page
D.J.A. Callen, M. M. Shroff, H. M. Branson, T. Lotze, D. K. Li, D. Stephens, and B. L. Banwell
MRI in the diagnosis of pediatric multiple sclerosis
Neurology, March 17, 2009; 72(11): 961 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F G Joseph, C L Hirst, T P Pickersgill, Y Ben-Shlomo, N P Robertson, and N J Scolding
CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients
J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 292 - 296.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Broadley, D Vanags, B Williams, B Johnson, D Feeney, L Griffiths, S Shakib, G Brown, A Coulthard, P Mullins, et al.
Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis
Multiple Sclerosis, March 1, 2009; 15(3): 329 - 336.
[Abstract] [PDF]


Home page
IOVSHome page
H. Merle, S. Olindo, A. Donnio, R. Richer, D. Smadja, and P. Cabre
Retinal Peripapillary Nerve Fiber Layer Thickness in Neuromyelitis Optica
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4412 - 4417.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Dwyer, I. van der Mei, A-L Ponsonby, B. V. Taylor, J. Stankovich, J. D. McKay, R. J. Thomson, A. M. Polanowski, and J. L. Dickinson
Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis
Neurology, August 19, 2008; 71(8): 583 - 589.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, et al.
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
Brain, July 1, 2008; 131(7): 1759 - 1775.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
T. Matsushita, T. Matsuoka, T. Ishizu, H. Kikuchi, M. Osoegawa, Y. Kawano, F. Mihara, Y. Ohyagi, and J.-i. Kira
Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study
Multiple Sclerosis, April 1, 2008; 14(3): 343 - 353.
[Abstract] [PDF]


Home page
Arch OphthalmolHome page
M. J. Dinkin, D. M. Cestari, M. C. Stein, S. D. Brass, and S. Lessell
NMO Antibody-Positive Recurrent Optic Neuritis Without Clear Evidence of Transverse Myelitis
Arch Ophthalmol, April 1, 2008; 126(4): 566 - 570.
[Full Text] [PDF]


Home page
Arch NeurolHome page
R. Eichel, Z. Meiner, O. Abramsky, and M. Gotkine
Acute Disseminating Encephalomyelitis in Neuromyelitis Optica: Closing the Floodgates
Arch Neurol, February 1, 2008; 65(2): 267 - 271.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Matsuoka, T. Matsushita, Y. Kawano, M. Osoegawa, H. Ochi, T. Ishizu, M. Minohara, H. Kikuchi, F. Mihara, Y. Ohyagi, et al.
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese
Brain, May 1, 2007; 130(5): 1206 - 1223.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. L. Banwell
The long (-itudinally extensive) and the short of it: Transverse myelitis in children
Neurology, May 1, 2007; 68(18): 1447 - 1449.
[Full Text] [PDF]


Home page
NeurologyHome page
B. Banwell, M. Shroff, J. M. Ness, D. Jeffery, S. Schwid, B. Weinstock-Guttman, and for the International Pediatric MS Study Group
MRI features of pediatric multiple sclerosis
Neurology, April 17, 2007; 68(16_suppl_2): S46 - S53.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I.A.F. van der Mei, L. Blizzard, A-L. Ponsonby, and T. Dwyer
Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1538 - 1544.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. M. Wingerchuk, V. A. Lennon, S. J. Pittock, C. F. Lucchinetti, and B. G. Weinshenker
Revised diagnostic criteria for neuromyelitis optica
Neurology, May 23, 2006; 66(10): 1485 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
C.S. Yu, F.C. Lin, K.C. Li, T.Z. Jiang, C.Z. Zhu, W. Qin, H. Sun, and P. Chan
Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1009 - 1015.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. W. O'Connor, D. Li, M. S. Freedman, A. Bar-Or, G.P.A. Rice, C. Confavreux, D. W. Paty, J. A. Stewart, R. Scheyer, and on behalf of the Teriflunomide Multiple Sclerosis
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
Neurology, March 28, 2006; 66(6): 894 - 900.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
E T Lim, F Sellebjerg, C V Jensen, D R Altmann, D Grant, G Keir, E J Thompson, and G Giovannoni
Acute axonal damage predicts clinical outcome in patients with multiple sclerosis
Multiple Sclerosis, October 1, 2005; 11(5): 532 - 536.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
W. Staffen, H. Zauner, A. Mair, A. Kutzelnigg, P. Kapeller, H. Stangl, E. Raffer, H. Niederhofer, and G. Ladurner
Magnetic Resonance Spectroscopy of Memory and Frontal Brain Region in Early Multiple Sclerosis
J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 357 - 363.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
R C Dale and J A Branson
Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis?
Arch. Dis. Child., June 1, 2005; 90(6): 636 - 639.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. G. Roed, A. Langkilde, F. Sellebjerg, M. Lauritzen, P. Bang, A. Morup, and J. L. Frederiksen
A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis
Neurology, March 8, 2005; 64(5): 804 - 810.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Laura, W. Leong, N. M.F. Murray, G. Ingle, K. A. Miszkiel, D. R. Altmann, D. H. Miller, and M. M. Reilly
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord
Neurology, March 8, 2005; 64(5): 914 - 916.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C. H Polman, J. S Wolinsky, and S. C Reingold
Multiple sclerosis diagnostic criteria: three years later
Multiple Sclerosis, February 1, 2005; 11(1): 5 - 12.
[Abstract] [PDF]


Home page
JAMAHome page
A.-L. Ponsonby, I. van der Mei, T. Dwyer, L. Blizzard, B. Taylor, A. Kemp, R. Simmons, and T. Kilpatrick
Exposure to Infant Siblings During Early Life and Risk of Multiple Sclerosis
JAMA, January 26, 2005; 293(4): 463 - 469.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Bakshi, G. J. Hutton, J. R. Miller, and E.-W. Radue
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis
Neurology, December 14, 2004; 63(11_suppl_5): S3 - S11.
[Abstract] [Full Text]


Home page
Mult SclerHome page
A. Kheradvar, A. R. Tabassi, B. Nikbin, F. Khosravi, M. Naroueynejad, B. Moradi, and A. A. Amirzargar
Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study
Multiple Sclerosis, October 1, 2004; 10(5): 526 - 531.
[Abstract] [PDF]


Home page
Mult SclerHome page
E T Lim, D Grant, M Pashenkov, G Keir, E J Thompson, M Soderstrom, and G Giovannoni
Cerebrospinal fluid levels of brain specific proteins in optic neuritis
Multiple Sclerosis, June 1, 2004; 10(3): 261 - 265.
[Abstract] [PDF]


Home page
NeurologyHome page
C. D. Hahn, M. M. Shroff, S. I. Blaser, and B. L. Banwell
MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort
Neurology, March 9, 2004; 62(5): 806 - 808.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. A. Asghar-Ali, K. H. Taber, R. A. Hurley, and L. A. Hayman
Pure Neuropsychiatric Presentation of Multiple Sclerosis
Am J Psychiatry, February 1, 2004; 161(2): 226 - 231.
[Full Text] [PDF]


Home page
Arch NeurolHome page
J. Sastre-Garriga, M. Tintore, A. Rovira, C. Nos, J. Rio, A. J. Thompson, and X. Montalban
Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
Arch Neurol, February 1, 2004; 61(2): 222 - 224.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. C.J. Bot, F. Barkhof, C. H. Polman, G.J. L. a Nijeholt, V. de Groot, E. Bergers, H. J. Ader, and J. A. Castelijns
Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination
Neurology, January 27, 2004; 62(2): 226 - 233.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
V Zipoli, E Portaccio, G Siracusa, G Pracucci, S Sorbi, and M P Amato
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis
Multiple Sclerosis, October 1, 2003; 9(5): 481 - 485.
[Abstract] [PDF]


Home page
NeurologyHome page
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, et al.
The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, September 9, 2003; 61(5): 602 - 611.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
I A F van der Mei, A-L Ponsonby, T Dwyer, L Blizzard, R Simmons, B V Taylor, H Butzkueven, and T Kilpatrick
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
BMJ, August 9, 2003; 327(7410): 316.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
Y P Jin, J de Pedro-Cuesta, Y H Huang, and M Soderstrom
Predicting multiple sclerosis at optic neuritis onset
Multiple Sclerosis, April 1, 2003; 9(2): 135 - 141.
[Abstract] [PDF]


Home page
Mult SclerHome page
G V McDonnell, J Cabrera-Gomez, D B Calne, D K. Li, and J Oger
Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: The subclinical stage of primary progressive multiple sclerosis may last 10 years
Multiple Sclerosis, April 1, 2003; 9(2): 204 - 209.
[Abstract] [PDF]


Home page
Mult SclerHome page
J Sastre-Garriga, M Tintore, A Rovira, E Grive, I Pericot, M Comabella, A J Thompson, and X Montalban
C onversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fl uid and neurophysiological findings
Multiple Sclerosis, February 1, 2003; 9(1): 39 - 43.
[Abstract] [PDF]


Home page
Mult SclerHome page
F Sellebjerg, C V Jensen, H B. Larsson, and J L Frederiksen
Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis
Multiple Sclerosis, February 1, 2003; 9(1): 102 - 107.
[Abstract] [PDF]


Home page
NeurologyHome page
CHAMPS Study Group
MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group
Neurology, October 8, 2002; 59(7): 998 - 1005.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R M Papais-Alvarenga, C M Miranda-Santos, M Puccioni-Sohler, A M V de Almeida, S Oliveira, C A B. De Oliveira, H Alvarenga, and C M Poser
Optic neuromyelitis syndrome in Brazilian patients
J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 429 - 435.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. O'Connor
Key issues in the diagnosis and treatment of multiple sclerosis: An overview
Neurology, September 24, 2002; 59(90063): S1 - 33.
[Full Text]


Home page
Mult SclerHome page
M. Rovaris, M. Holtmannspotter, M. Rocca, G. Iannucci, M. Codella, B. Viti, A. Campi, G. Comi, T. Yousry, and M. Filippi
Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study
Multiple Sclerosis, September 1, 2002; 8(1_suppl): 52 - 58.
[Abstract] [PDF]


Home page
Mult SclerHome page
A. van der Meijs, I. Tan, and F. Barkhof
Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis
Multiple Sclerosis, September 1, 2002; 8(1_suppl): 64 - 67.
[Abstract] [PDF]


Home page
Mult SclerHome page
H. McFarland
The emerging role of MRI in multiple sclerosis and the new diagnostic criteria
Multiple Sclerosis, September 1, 2002; 8(1_suppl): 71 - 72.
[PDF]


Home page
Mult SclerHome page
CHAMPS Study Group
Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial
Multiple Sclerosis, August 1, 2002; 8(4): 330 - 338.
[Abstract] [PDF]


Home page
BrainHome page
W. Staffen, A. Mair, H. Zauner, J. Unterrainer, H. Niederhofer, A. Kutzelnigg, S. Ritter, S. Golaszewski, B. Iglseder, and G. Ladurner
Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task
Brain, June 1, 2002; 125(6): 1275 - 1282.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. L. Arnold and P.M. Matthews
MRI in the diagnosis and management of multiple sclerosis
Neurology, April 23, 2002; 58(90084): S23 - 31.
[Abstract] [Full Text]


Home page
Mult SclerHome page
A Ghezzi, C Pozzilli, M Liguori, M G Marrosu, N Milani, C Milanese, I Simone, and M Zaffaroni
Prospective study of multiple sclerosis with early onset
Multiple Sclerosis, April 1, 2002; 8(2): 115 - 118.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Rovaris, M Holtmannspotter, M A Rocca, G Iannucci, M Codella, B Viti, A Campi, G Comi, T A Yousry, and M Filippi
Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study
Multiple Sclerosis, February 1, 2002; 8(1): 52 - 58.
[Abstract] [PDF]


Home page
Mult SclerHome page
A H. van der Meijs, I L Tan, and F Barkhof
Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis
Multiple Sclerosis, February 1, 2002; 8(1): 64 - 67.
[Abstract] [PDF]


Home page
Mult SclerHome page
H F McFarland
The emerging role of MRI in multiple sclerosis and the new diagnostic criteria
Multiple Sclerosis, February 1, 2002; 8(1): 71 - 72.
[PDF]


Home page
Mult SclerHome page
M Tintore, A Rovira, L Brieva, E Grive, R Jardi, C Borras, and X Montalban
Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS
Multiple Sclerosis, December 1, 2001; 7(6): 359 - 363.
[Abstract] [PDF]


Home page
NeurologyHome page
E. M. Frohman, H. Zhang, P. D. Kramer, J. Fleckenstein, K. Hawker, M. K. Racke, and T. C. Frohman
MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis
Neurology, September 11, 2001; 57(5): 762 - 768.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. de Seze, T. Stojkovic, G. Breteau, C. Lucas, U. Michon-Pasturel, J.-Y. Gauvrit, E. Hachulla, F. Mounier-Vehier, J.-P. Pruvo, D. Leys, et al.
Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases
Brain, August 1, 2001; 124(8): 1509 - 1521.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Schwarz, A. Mohr, M. Knauth, B. Wildemann, and B. Storch-Hagenlocher
Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients
Neurology, May 22, 2001; 56(10): 1313 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
L. Belopitova, V. Guergueltcheva, and V. Bojinova
Definite and Suspected Multiple Sclerosis in Children: Long-Term Follow-up and Magnetic Resonance Imaging Findings
J Child Neurol, May 1, 2001; 16(5): 317 - 324.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. Pelletier, L. Suchet, T. Witjas, M. Habib, C. R. G. Guttmann, G. Salamon, O. Lyon-Caen, and A. A. Cherif
A Longitudinal Study of Callosal Atrophy and Interhemispheric Dysfunction in Relapsing-Remitting Multiple Sclerosis
Arch Neurol, January 1, 2001; 58(1): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. R. W. Moore, E. Leung, A. L. MacKay, I. M. Vavasour, K. P. Whittall, K. S. Cover, D. K. B. Li, S. A. Hashimoto, J. Oger, T. J. Sprinkle, et al.
A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain
Neurology, November 28, 2000; 55(10): 1506 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Filippi
Enhanced magnetic resonance imaging in multiple sclerosis
Multiple Sclerosis, October 1, 2000; 6(5): 320 - 326.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. W. Paty
Ultrasound Measurement of Brain Atrophy in Multiple Sclerosis
Arch Neurol, September 1, 2000; 57(9): 1264 - 1264.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
G. Iannucci, C. Tortorella, M. Rovaris, M. P. Sormani, G. Comi, and M. Filippi
Prognostic Value of MR and Magnetization Transfer Imaging Findings in Patients withClinically Isolated Syndromes Suggestive ofMultiple Sclerosis at Presentation
AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1034 - 1038.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
J. S. Kaiser, R. I. Grossman, M. Polansky, J. K. Udupa, Y. Miki, and S. L. Galetta
Magnetization Transfer Histogram Analysis of Monosymptomatic Episodes of Neurologic Dysfunction: Preliminary Findings
AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1043 - 1047.
[Abstract] [Full Text]


Home page
NeurologyHome page
G. S. Gronseth and E. J. Ashman
Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology, May 9, 2000; 54(9): 1720 - 1725.
[Full Text] [PDF]


Home page
Mult SclerHome page
M Kremenchutzky, D Lee, G P A Rice, and G C Ebers
Diagnostic brain MRI findings in primary progressive multiple sclerosis
Multiple Sclerosis, April 1, 2000; 6(2): 81 - 85.
[Abstract] [PDF]


Home page
Mult SclerHome page
I L Tan, G J L. Nijeholt, C H Polman, H J Ader, F Barkhof, and the 95 Line 146/147 Study Group
Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials
Multiple Sclerosis, April 1, 2000; 6(2): 99 - 104.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Tintoré, A. Rovira, M. J. Martínez, J. Rio, P. Díaz-Villoslada, L. Brieva, C. Borrás, E. Grivé, J. Capellades, and X. Montalban
Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 702 - 706.
[Abstract] [Full Text]


Home page
Mult SclerHome page
S. Mata, F. Lolli, M. Soderstrom, F. Pinto, and H. Link
Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD I a
Multiple Sclerosis, December 1, 1999; 5(6): 379 - 388.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Filippi, M. A. Rocca, M. Wiessmann, S. Mennea, M. Cercignani, T. A. Yousry, M. P. Sormani, and G. Comi
A Comparison of MR Imaging with Fast-FLAIR, HASTE-FLAIR, and EPI-FLAIR Sequences in the Assessment of Patients with Multiple Sclerosis
AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1931 - 1938.
[Abstract] [Full Text]


Home page
NeurologyHome page
M. A. Hernan, M. J. Olek, and A. Ascherio
Geographic variation of MS incidence in two prospective studies of US women
Neurology, November 1, 1999; 53(8): 1711 - 1711.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. M. Wingerchuk, W. F. Hogancamp, P. C. O'Brien, and B. G. Weinshenker
The clinical course of neuromyelitis optica (Devic's syndrome)
Neurology, September 1, 1999; 53(5): 1107 - 1107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
G. Mastronardo, M. A. Rocca, G. Iannucci, C. Pereira, and M. Filippi
A Longitudinal MR Study of the Presymptomatic Phase in a Patient with Clinically Definite Multiple Sclerosis
AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1268 - 1272.
[Abstract] [Full Text]


Home page
NeurologyHome page
F. Fazekas, F. Barkhof, M. Filippi, R. I. Grossman, D. K. B. Li, W. I. McDonald, H. F. McFarland, D. W. Paty, J. H. Simon, J. S. Wolinsky, et al.
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis
Neurology, August 1, 1999; 53(3): 448 - 448.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Filippi, M. A. Rocca, L. Minicucci, V. Martinelli, A. Ghezzi, R. Bergamaschi, and G. Comi
Magnetization transfer imaging of patients with definite MS and negative conventional MRI
Neurology, March 1, 1999; 52(4): 845 - 845.
[Abstract] [Full Text]


Home page
NeurologyHome page
M. Sailer, J. I. O'Riordan, A. J. Thompson, D. P. Kingsley, D. G. MacManus, W. I. McDonald, and D. H. Miller
Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination
Neurology, February 1, 1999; 52(3): 599 - 599.
[Abstract] [Full Text]


Home page
Mult SclerHome page
J L Frederiksen
Can CSF predict the course of optic neuritis?
Multiple Sclerosis, June 1, 1998; 4(3): 132 - 135.
[Abstract] [PDF]


Home page
Arch NeurolHome page
A. Tourbah, A. Clapin, O. Gout, B. Fontaine, R. Liblau, F. Batteux, J.-L. Stievenart, B. Weill, C. Lubetzki, and O. Lyon-Caen
Systemic Autoimmune Features and Multiple Sclerosis: A 5-Year Follow-up Study
Arch Neurol, April 1, 1998; 55(4): 517 - 521.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. J. Khoury and H. L. Weiner
Multiple Sclerosis: What Have We Learned From Magnetic Resonance Imaging Studies?
Arch Intern Med, March 23, 1998; 158(6): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J I O'Riordan, N A Losseff, C Phatouros, A J Thompson, I F Moseley, D G MacManus, W I McDonald, and D H Miller
Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination
J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 353 - 357.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. L Frederiksen and C. J. Sindic
Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI
Multiple Sclerosis, February 1, 1998; 4(1): 22 - 26.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C A Davie, G J Barker, A J Thompson, P S Tofts, W I McDonald, and D H Miller
1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, December 1, 1997; 63(6): 736 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F. Thomke, E. Lensch, K. Ringel, and H. C. Hopf
Isolated cranial nerve palsies in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 682 - 685.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
F. Barkhof
Imaging of remyelination
Multiple Sclerosis, April 1, 1997; 3(2): 129 - 132.
[Abstract] [PDF]


Home page
DTBHome page
{blacktriangledown}Interferon beta-1b - hope or hype?
DTB, February 1, 1996; 34(2): 9 - 11.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Soderstrom, J Hillert, J Link, V Navikas, S Fredrikson, and H Link
Expression of IFN-{gamma}, IL-4, and TGF-{beta} in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease
Multiple Sclerosis, November 1, 1995; 1(3): 173 - 180.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. P. Amato, G. Ponziani, G. Pracucci, L. Bracco, G. Siracusa, and L. Amaducci
Cognitive Impairment in Early-Onset Multiple Sclerosis: Pattern, Predictors, and Impact on Everyday Life in a 4-Year Follow-up
Arch Neurol, February 1, 1995; 52(2): 168 - 172.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. E. Goodkin, R. A. Rudick, and J. S. Ross
The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol, May 1, 1994; 51(5): 505 - 516.
[Abstract] [PDF]


Home page
Arch NeurolHome page
P. O'Connor, C. Tansey, W. Kucharczyk, A. S. Detsky, and Rochester-Toronto MRI Study Group
A Randomized Trial of Test Result Sequencing in Patients With Suspected Multiple Sclerosis
Arch Neurol, January 1, 1994; 51(1): 53 - 59.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. W. Giang, V. M. Grow, C. Mooney, A. I. Mushlin, A. D. Goodman, D. H. Mattson, R. B. Schiffer, and Rochester-Toronto Magnetic Resonance Study Group
Clinical Diagnosis of Multiple Sclerosis: The Impact of Magnetic Resonance Imaging and Ancillary Testing
Arch Neurol, January 1, 1994; 51(1): 61 - 66.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. W. Beck, J. Arrington, F. R. Murtagh, P. A. Cleary, D. I. Kaufman, and Optic Neuritis Study Group
Brain Magnetic Resonance Imaging in Acute Optic Neuritis: Experience of the Optic Neuritis Study Group
Arch Neurol, August 1, 1993; 50(8): 841 - 846.
[Abstract] [PDF]


Home page
JAMAHome page
A. I. Mushlin, A. S. Detsky, C. E. Phelps, P. W. O'Connor, D. K. Kido, W. Kucharczyk, D. W. Giang, C. Mooney, C. M. Tansey, W. J. Hall, et al.
The Accuracy of Magnetic Resonance Imaging in Patients With Suspected Multiple Sclerosis
JAMA, June 23, 1993; 269(24): 3146 - 3151.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
K. Syndulko, W. W. Tourtellotte, R. W. Baumhefner, G. W. Ellison, L. W. Myers, G. Belendiuk, and G. V. Kondraske
Neuroperformance Evaluation of Multiple Sclerosis Disease Progression in a Clinical Trial: Implications for Neurological Outcomes
Neurorehabil Neural Repair, January 1, 1993; 7(3-4): 153 - 176.
[PDF]


Home page
ANN INTERN MEDHome page
A. Gessain and O. Gout
Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I)
Ann Intern Med, December 1, 1992; 117(11): 933 - 946.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. A. Rudick
The Value of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol, July 1, 1992; 49(7): 685 - 686.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. Ramirez-Lassepas, J. W. Tulloch, M. R. Quinones, and B. D. Snyder
Acute Radicular Pain as a Presenting Symptom in Multiple Sclerosis
Arch Neurol, March 1, 1992; 49(3): 255 - 258.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. E. Goodkin, T. H. Doolittle, S. S. Hauser, R. M. Ransohoff, A. D. Roses, and R. A. Rudick
Diagnostic Criteria for Multiple Sclerosis Research Involving Multiply Affected Families
Arch Neurol, August 1, 1991; 48(8): 805 - 807.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.